Company Performance Metrics
- Mark Reisenauer: Chief Executive Officer
- Howard Franklin: Senior Vice PresidentPast Role: Salix Pharmaceuticals, Chief Medical Officer
Assertio develops and commercializes prescription pharmaceutical products focused on neurology, oncology, pain management, and inflammation-related conditions. The company markets branded medicines used for migraine treatment, seizure disorders, post-surgical pain, arthritis, and oncology supportive care. Its operations include product
commercialization, medical affairs, regulatory management, licensing activities, and portfolio expansion through acquisitions and strategic partnerships. Assertio also manages specialty pharmaceutical programs that support physician engagement, patient access services, and distribution across healthcare channels.
The company’s portfolio includes both internally managed and licensed therapies across multiple therapeutic categories within specialty pharmaceuticals. It uses a commercial infrastructure that combines digital engagement, field sales operations, and healthcare provider support programs to manage product distribution and adoption. Assertio continues to expand its business through acquisition and licensing strategies involving specialty and branded pharmaceutical assets.
